"Daily life of CAPS patients treated with canakinumab (Ilaris®) : data from the French observational study - ENVOL Study". Issue 1 (December 2015) - Koné-Paut, I; Quartier, P; Fain, O; Grateau, G; Pillet, P; Le Blay, P; Bonnet, F; Despert, V; Stankovic, K; Willemins, L; Queré, S; Reigneau, O; et al.